Janus kinase inhibitors in dermatology: Part I. A comprehensive review

被引：35

作者：

Chapman, Stephanie ^{[1
]}

Kwa, Michael ^{[1
]}

Gold, Linda Stein ^{[1
]}

Lim, Henry W. ^{[1
]}

机构：

[1] Henry Ford Hlth Syst, Dept Dermatol, 3031 W Grand Blvd,Suite 800, Detroit, MI 48202 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 86卷 / 02期

关键词：

dermatology; immunodermatology; immunology; JAK inhibitor; JAK-STAT pathway; Janus kinase inhibitor; Janus kinase-signal transducer and activator of transcription pathway; review; EOSINOPHILIA; TOFACITINIB; DERMATITIS; PSORIASIS; EFFICACY; PHASE-3; SKIN;

D O I：

10.1016/j.jaad.2021.07.002

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The Janus kinase-signal transducer and activator of transcription (JAK-STAT) intracellular signaling pathway is utilized by many proinflammatory molecules to mediate downstream effects and activate gene transcription. Activation of the JAK-STAT pathway contributes to a number of inflammatory dermatoses. Clinical trials and smaller studies have demonstrated the efficacy of JAK inhibitors in the treatment of a variety of dermatologic conditions. Here, we review the use of JAK inhibitors for the treatment of a wide range of dermatologic diseases in a two-part review series. ( J Am Acad Dermatol 2022;86:406-13.)

引用

页码：406 / 413

页数：8

共 50 条

[31] Emerging role of topical Janus kinase inhibitors in dermatological disorders: a review
Dogra, Sunil
Sharma, Apoorva
Mehta, Hitaishi
Sarkar, Rashmi
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (10) : 1102 - 1112
[32] Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
Rygula, Izabella
Pikiewicz, Wojciech
Kaminiow, Konrad
MOLECULES, 2023, 28 (24):
[33] Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
Papierzewska, Malgorzata
Waskiel-Burnat, Anna
Rudnicka, Lidia
CLINICAL DRUG INVESTIGATION, 2023, 43 (05) : 325 - 334
[34] Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis
Juan, Hui Yu
Sheu, Shwu-Jiuan
Hwang, De-Kuang
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2025, 41 (02) : 44 - 53
[35] Janus kinase inhibitors
Witte, Torsten
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (02): : 94 - 99
[36] Janus kinase inhibitors for alopecia areata: A narrative review
Haughton, Renee D.
Herbert, Samantha M.
Ji-Xu, Antonio
Downing, Lauren
Raychaudhuri, Siba P.
Maverakis, Emanual
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2023, 89 (06) : 799 - 806
[37] Janus kinase inhibitors
Ostermeier, E.
Roll, P.
Tony, H. -P.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2012, 71 (06): : 473 - 478
[38] Updates on efficacy and safety janus kinase inhibitors in juvenile dermatomyositis
Kim, Hanna
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (06) : 589 - 602
[39] The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
Kim, Jin-Woo
Kim, Su-Young
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
[40] Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
Singh, Rhea
Heron, Courtney E.
Ghamrawi, Rima, I
Strowd, Lindsay C.
Feldman, Steven R.
IMMUNOTARGETS AND THERAPY, 2020, 9 : 255 - 272

← 1 2 3 4 5 →